Suzhou Ribo Life Science Co (HKSE:06938) Net Margin %: -424.95% (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:06938 Suzhou Ribo Life Science Co Ltd HKSE:06938
9 GF Score
Price HK$54.15
! 2 Warning Signs
View Full Analysis

What is Suzhou Ribo Life Science Co Net Margin %?

Suzhou Ribo Life Science Co HKSE:06938 -4.07% 9 Net Margin % is -424.95% as of Dec. 2025. GuruFocus rates HKSE:06938 with a GF Score™ of 9/100. The stock has 2 warning signs investors should review. Among 948 Biotechnology companies, Suzhou Ribo Life Science Co ranks better than 57.17% on this metric.

Net margin is calculated as Net Income divided by its Revenue. Suzhou Ribo Life Science Co's Net Income for the six months ended in Dec. 2025 was HK$-209.8 Mil. Suzhou Ribo Life Science Co's Revenue for the six months ended in Dec. 2025 was HK$49.4 Mil. Therefore, Suzhou Ribo Life Science Co's net margin for the quarter that ended in Dec. 2025 was -424.95%.

The historical rank and industry rank for Suzhou Ribo Life Science Co's Net Margin % or its related term are showing as below:

HKSE:06938' s Net Margin % Range Over the Past 10 Years
Min: -976081.25   Med: -189.41   Max: -34.84
Current: -34.84

HKSE:06938's Net Margin % is ranked better than
57.17% of 948 companies
in the Biotechnology industry
Industry Median: -75.55 vs HKSE:06938: -34.84

Suzhou Ribo Life Science Co  (HKSE:06938) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Suzhou Ribo Life Science Co Net Margin % Related Terms

Suzhou Ribo Life Science Co Net Margin % Historical Data

* Premium members only.

The historical data trend for Suzhou Ribo Life Science Co's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Suzhou Ribo Life Science Co Net Margin % Chart

Suzhou Ribo Life Science Co Annual Data
Trend Dec23 Dec24 Dec25
Net Margin %
-976,081.25 -189.41 -187.23

Suzhou Ribo Life Science Co Semi-Annual Data
Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Net Margin % Get a 7-Day Free Trial -207.43 -173.75 -84.88 -424.95 4.84

HKSE:06938 vs VRTX, REGN, MRNA: Net Margin % Comparison

For the Biotechnology subindustry, Suzhou Ribo Life Science Co's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Suzhou Ribo Life Science Co Net Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Suzhou Ribo Life Science Co's Net Margin % distribution charts can be found below:

* The bar in red indicates where Suzhou Ribo Life Science Co's Net Margin % falls into.


HKSE:06938
9GF Score
Suzhou Ribo Life Science Co Ltd HKSE:06938
Net Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Suzhou Ribo Life Science Co Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Suzhou Ribo Life Science Co's Net Margin for the fiscal year that ended in Dec. 2025 is calculated as

Net Margin=Net Income (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-307.179/164.063
=-187.23 %

Suzhou Ribo Life Science Co's Net Margin for the quarter that ended in Dec. 2025 is calculated as

Net Margin=Net Income (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=-209.833/49.378
=-424.95 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Net Margin % →
What does a Net Margin % of -424.95% mean?
Suzhou Ribo Life Science Co (HKSE:06938) has a Net Margin % of -424.95% as of Dec. 2025. Net margin is the ratio of total net income to net sales. View historical data on Suzhou Ribo Life Science Co and its competitors. According to the industry distribution chart, Suzhou Ribo Life Science Co ranks #406 out of 948 companies in the Biotechnology industry, placing it in the top 42.8%.
Is Suzhou Ribo Life Science Co's Net Margin % too high?
Suzhou Ribo Life Science Co's current Net Margin % is -424.95%. Based on the distribution chart, Suzhou Ribo Life Science Co ranks #406 out of 948 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Suzhou Ribo Life Science Co has a GF Score™ of 9/100, reflecting its overall financial health beyond just this single metric.
How does Suzhou Ribo Life Science Co's Net Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Suzhou Ribo Life Science Co ranks #406 out of 948 companies for Net Margin %. This puts Suzhou Ribo Life Science Co in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Biotechnology company?
A good Net Margin % depends on the Biotechnology industry context. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Suzhou Ribo Life Science Co and its competitors. Suzhou Ribo Life Science Co's current Net Margin % is -424.95%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Suzhou Ribo Life Science Co stock overvalued right now?
Suzhou Ribo Life Science Co (HKSE:06938) has a current Net Margin % of -424.95%. The current Net Margin % is -424.95%. Suzhou Ribo Life Science Co's overall GF Score™ is 9/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Suzhou Ribo Life Science Co (HKSE:06938), the current Net Margin % is -424.95% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Suzhou Ribo Life Science Co Business Description

Address No. 168 Yuanfeng Road, Yushan Town, Jiangsu Province, Kunshan, CHN, 215300
Suzhou Ribo Life Science Co Ltd is a biopharmaceutical company engaged in oligonucleotide R&D, with a focus on siRNA therapeutics. The company's pipeline focuses on cardiovascular, metabolic, renal and liver diseases. Its pipeline includes RBD4059, RBD5044, RBD7007, RBD1119, RBD3103, SR122, SR126, RBD1016, SR112/SR113, among others. It has one reportable operating segment.
9GF Score

Get the complete analysis for HKSE:06938

Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$54.15
Price